Cite
Hasegawa Y, Tsukahara K, Yoshimoto S, et al. Reply to P. Kaul et al. J Clin Oncol. 2021;39(31):3518-3519doi: 10.1200/JCO.21.01554.
Hasegawa, Y., Tsukahara, K., Yoshimoto, S., Miura, K., Yokoyama, J., Hirano, S., Uemura, H., Sugasawa, M., Yoshizaki, T., Homma, A., Chikamatsu, K., Suzuki, M., Shiotani, A., Matsuzuka, T., Kohno, N., Miyazaki, M., Oze, I., Matsuo, K., Kosuda, S., & Yatabe, Y. (2021). Reply to P. Kaul et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(31), 3518-3519. https://doi.org/10.1200/JCO.21.01554
Hasegawa, Yasuhisa, et al. "Reply to P. Kaul et al." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 39,31 (2021): 3518-3519. doi: https://doi.org/10.1200/JCO.21.01554
Hasegawa Y, Tsukahara K, Yoshimoto S, Miura K, Yokoyama J, Hirano S, Uemura H, Sugasawa M, Yoshizaki T, Homma A, Chikamatsu K, Suzuki M, Shiotani A, Matsuzuka T, Kohno N, Miyazaki M, Oze I, Matsuo K, Kosuda S, Yatabe Y. Reply to P. Kaul et al. J Clin Oncol. 2021 Nov 01;39(31):3518-3519. doi: 10.1200/JCO.21.01554. Epub 2021 Sep 10. PMID: 34506232.
Copy
Download .nbib